These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28868507)

  • 1. Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment.
    Kim A; Hoe KO; Shin JH; Choo MS
    Investig Clin Urol; 2017 Sep; 58(5):353-358. PubMed ID: 28868507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Voiding Dysfunction Phenotypes in Women with Interstitial Cystitis/Bladder Pain and Myofascial Pelvic Pain: Results from the ICEPAC Trial.
    Petrikovets A; Veizi IE; Hijaz A; Mahajan ST; Daneshgari F; Buffington CAT; McCabe P; Chelimsky T
    Urology; 2019 Apr; 126():54-58. PubMed ID: 30682465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
    Wang J; Wang Q; Wu Q; Chen Y; Wu P
    Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Cervigni M; Nasta L; Schievano C; Lampropoulou N; Ostardo E
    Biomed Res Int; 2019; 2019():9828397. PubMed ID: 31828153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional somatic syndromes as risk factors for hysterectomy in early bladder pain syndrome/interstitial cystitis.
    Warren JW; Clauw DJ; Wesselmann U; Howard FM; Gallicchio L; Morozov V
    J Psychosom Res; 2014 Nov; 77(5):363-7. PubMed ID: 25258358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
    Nickel JC; Shoskes D; Irvine-Bird K
    J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.
    Rais-Bahrami S; Friedlander JI; Herati AS; Sadek MA; Ruzimovsky M; Moldwin RM
    BJU Int; 2012 May; 109(9):1356-9. PubMed ID: 21883848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voiding diary might serve as a useful tool to understand differences between bladder pain syndrome/interstitial cystitis and overactive bladder.
    Kim SH; Oh SA; Oh SJ
    Int J Urol; 2014 Feb; 21(2):179-83. PubMed ID: 23841824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
    Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
    Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology.
    Kuo YC; Kuo HC
    Neurourol Urodyn; 2018 Aug; 37(6):1971-1977. PubMed ID: 29504632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis.
    Kuo HC
    J Formos Med Assoc; 2001 May; 100(5):309-14. PubMed ID: 11432309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
    Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
    J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
    Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
    J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.